Showing results (151-160 of 348) with videos related to
Sort By:
Pageof 35
The Lancet. Neurology|September 3, 2018
Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional studyJuan Fortea, María Carmona-Iragui, Bessy Benejam, et al.Molecular Neurodegeneration|August 19, 2020
Cerebrospinal fluid profile of NPTX2 supports role of Alzheimer's disease-related inhibitory circuit dysfunction in adults with Down syndromeOlivia Belbin, Mei-Fang Xiao, Desheng Xu, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Dementia Care Research and Psychosocial FactorsLídia Vaqué-Alcázar, Laura Del Hoyo, Laura Videla, et al.Journal of Neurology, Neurosurgery, and Psychiatry|December 7, 2013
Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutationMarc Suárez-Calvet, Oriol Dols-Icardo, Albert Lladó, et al.Annals of Clinical and Translational Neurology|December 3, 2019
APP-derived peptides reflect neurodegeneration in frontotemporal dementiaIgnacio Illán-Gala, Jordi Pegueroles, Victor Montal, et al.Neurology|October 16, 2015
Use of amyloid-PET to determine cutpoints for CSF markers: A multicenter studyMarissa D Zwan, Juha O Rinne, Steen G Hasselbalch, et al.Neuropathology and Applied Neurobiology|January 26, 2023
Amyloid precursor protein 𝛽CTF accumulates in synapses in sporadic and genetic forms of Alzheimer's diseasePaula Ferrer-Raventós, David Puertollano-Martín, Marta Querol-Vilaseca, et al.Neurology|June 9, 2017
CSF sAPPβ, YKL-40, and neurofilament light in frontotemporal lobar degenerationDaniel Alcolea, Eduard Vilaplana, Marc Suárez-Calvet, et al.Movement Disorders : Official Journal of the Movement Disorder Society|December 17, 2011
Glucocerebrosidase mutations confer a greater risk of dementia during Parkinson's disease courseNúria Setó-Salvia, Javier Pagonabarraga, Henry Houlden, et al.Medrxiv : the Preprint Server for Health Sciences|November 22, 2024
Plasma p-tau212 as a biomarker of sporadic and Down Syndrome Alzheimer's diseasePrzemysław R Kac, Daniel Alcolea, Laia Montoliu-Gaya, et al.Pageof 35